POS1372 EVALUATION OF E148Q AND CONCOMITANT AA AMYLOIDOSIS SECONDARY TO FAMILIAL MEDITERRANEAN FEVER AFTER ADJUSTED CLINICAL-DEMOGRAPHIC CHARACTERISTICS
نویسندگان
چکیده
Background: Amyloid A (AA) amyloidosis, previously known as secondary or reactive is a long-recognized severe complication of some chronic inflammatory diseases. The pathogenesis and risk factors for amyloidosis in Familial Mediterranean Fever (FMF) remain partially understood (1). development AA dependent on ethnicity country residence (2). In the pre-colchicine era, renal AA-amyloidosis was largely reported patients Turkish (67%) Sephardic Jewish ancestry (26.5%) (2,3). Currently it’s well that MEFV M694V variant associated with high however, mutations exon 2, specifically E148Q remained controversial. Objectives: To evaluate mutation concomitant Amyloidosis to FMF after adjusted clinical-demographic characteristics. Methods: Patients were recruited from unit at Epigenetic Health Center outpatient clinic Turkey between September 2003 February 2020. who had biopsy confirmed related included study. Tel-Hashomer criteria applied diagnosis FMF. clinical characteristics medication history recorded by physician time registry entry. All detailed baseline assessment features, functions, genetic testing, histopathological treatment received. We performed multiple comparisons according age diagnosis, demographic disease phenotype, allele frequency, type mortality. Statistical analysis Package Social Science (SPSS) Windows, version 15.0 (SPSS Inc, Chicago, IL). Results: Our consists 195 amyloidosis. Complete information 169 (lost follow up, n=26) included. median 36 (19-49) years; male/female ratio 1.6 (104/65). follow-up duration years (4-17 years). There 101 diagnosed <18 68 ≥18 age. participants developed before 32 years. Family documented 56 (33.1%) family present 41 (24.3%). three most common symptoms fever (84,6%), abdominal pain (71.6%) arthritis (66.9%). During follow-up, 5 started dialysis 9 kidney transplantation. frequency across (60.6%), (21.4%) M680I (10.3%). frequent M694V/M694V (63.3%), M694V/E148Q (20.8%) E148Q/E148Q (15.8%). up period, 15 (10 male, female) died. those died, 14 M694V/M694Vand one demonstrated E148Q/E148Q. Conclusion: have an increased This study association FMF-associated which has been many studies. Close further evaluation warranted if residing endemic areas. possible relationship need be other cohorts. References: [1]Erer B, Demirkaya E, Ozen S, Kallinich T. What best acute phase reactant familial its role prediction complications? systematic review. Rheumatology international. 2016;36(4):483-7. [2]Touitou I, Sarkisian T, Medlej-Hashim M, Tunca Livneh A, Cattan D, et al. Country primary factor fever. Arthritis rheumatism. 2007;56(5):1706-12. [3]Pras Bronshpigel N, Zemer Gafni J. Variable incidence among different ethnic groups. Johns Hopkins Med 1982;150(1):22-6. Disclosure Interests: None declared
منابع مشابه
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
BACKGROUND There is no established treatment of AA amyloidosis, a long-term complication of various chronic inflammatory diseases associated with increased mortality, such as familial Mediterranian fever (FMF). Recently there are few reports pointing out that tocilizumab(TCZ), an anti IL-6 agent may be effective in AA amyloidosis resistant to conventional treatments. We report our data on the e...
متن کاملChronic familial Mediterranean fever with development of secondary amyloidosis.
A 20-year-old Turkish male presented with fever, abdominal pain, and systemic lethargy. His clinical history revealed symptoms to be self-limiting but reoccurring over the past six months. Blood and urine specimens collected indicated renal amyloidosis. A kidney CT image indicated kidney inflammation. He was diagnosed with Familial Mediterranean Fever with the development of secondary amyloidos...
متن کاملAA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations
A 54-year-old Japanese man presented with recurrent abdominal pain, fever lasting >5 days, and renal failure. AA amyloidosis was proven by renal and gastric biopsy. Symptoms subsided with the administration of colchicine, but a subsequent recurrence of symptoms did not respond to colchicine. Mediterranean fever gene (MEFV) analysis showed that he was heterozygous for mutations in exon 2 (E148Q/...
متن کاملLate ventricular potentials in familial Mediterranean fever with and without AA amyloidosis.
Objective Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by episodic and chronic inflammation that may lead to both accelerated coronary atherosclerosis and cardiac AA amyloidosis. We hypothesized that late ventricular potentials (LPs), an established electrocardiographic susceptibility marker of ventricular arrhythmias, will be more common in FMF than in the...
متن کاملClinical and demographic characteristics of children with familial mediterranean fever in Central Anatolia
Results The mean age of disease onset was 5.1 ± 3.6 years and the mean age at diagnosis was 7.3 ±3.1 years. The mean number of attacks per year was 7.7 ± 7.8, the mean duration of attacks 1.7 ± 1.6 days. The most common clinical manifestations were fever (91.6%) and abdominal pain (90.3%). The other manifestations were arthralgia (44.1%), arthritis (18.6%), headache (17.3%), myalgia (15.6%), vo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of the Rheumatic Diseases
سال: 2021
ISSN: ['1468-2060', '0003-4967']
DOI: https://doi.org/10.1136/annrheumdis-2021-eular.3420